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Abstract
Objectives: The aim of the study was to determine carotid
intima-media thickness (CIMT) values in patients who
developed and did not develop preeclampsia (PE), and to
determine whether CIMT values could be predictors of PE
development.
Methods: The study included pregnant women who were
examined by regular ultrasound examination at the
Materno-Infantil Presidente Vargas Hospital (HMIPV) in
PortoAlegre, Brazil, fromApril 2016 to September 2017. The
examinationswere performed every threemonths. Patients
were divided into two groups. The first group included
patients diagnosed with PE (n=21) and second group
included patients who did not have PE (n=199). A high
frequency ultrasound device (12 MHz) with a semi-
automatic method was used to estimate CIMT.
Results: CIMT was significantly higher in pregnant
women with PE than in women without PE (55±0.11 vs.
0.44±0.06, respectively; p<0.001). Using a cut-off value of
0.51 mm, CIMT had a specificity of 77.9% and sensitivity of
81% in the diagnosis of PE. With CIMT ≥0.6 mm, the
probability of a patient developing PE was 44.4%; with
CIMT >0.42 mm, the probability was only 4.2%.
Conclusions: An increase in CIMT was associated with the
onset of PE. CIMT values were significantly higher in pa-
tients who develop PE.
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Introduction
Atherosclerosis is the primary cause of cardiovascular
diseases [1]. The complication of atherosclerosis is athe-
rothrombosis which can have fatal consequences (cere-
brovascular and cardiovascular incidents). Given the high
percentage of potentially fatal complications of athero-
thrombosis (the process progresses through life, before
finally manifesting as an acute ischemic event), a proper
understanding of the pathogenesis of this disease is of
great importance for determining the optimal modalities of
prophylaxis and therapy [2, 3]. Atherosclerosis is a chronic
inflammatory process in the arteria intima and is charac-
terized by thinning of the blood vessel intima, with lipids
and macrophage accumulation [2, 3]. Preeclampsia (PE) is
a multisystemic disease, complicating 3–8% of pregnan-
cies, and is one of the largest causes of maternal mortality
[4, 5]. It is defined as newonset hypertension after 20weeks
of gestation with systolic blood pressure (BP) >140 mmHg
or diastolic BP ≥90 mmHg and significant proteinuria
300 mg of protein in 24 h [6, 7]. Pathophysiological con-
sequences are impaired placental perfusion and conse-
quent involvement of the whole organism including renal,
hematologic, hepatological and neurological complications
and fetal growth retardation [6, 7]. Risk factors for athero-
sclerosis are also risk factors for PE [8, 9]. Thefirst step in the
process of atherosclerosis is increase in carotid intima-
media thickness (CIMT) [2, 3]. CIMT is associated with the
onset of incident hypertension in a population without
already verified hypertension [10]. Endothelial dysfunction,
the basis of the onset of atherothrombosis, is the process
underlying the PE [11, 12]. Endothelial dysfunction contrib-
utes to the degree of PE [13]. Dysfunctional endothelium is
characterized by reduced nitric oxide bioavailability and
overproduction of endothelin one, which impairs vascular
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hemostasis; increased expression of adhesion molecules
and increased blood thrombogenicity through excretion of
locally active substances [2, 3]. Prediction of PE onset for
optimal therapeutic modality and prevention of the effects
of PE on the mother and fetus is a goal in the daily work of
the clinician. The use of non-invasive, high-resolution
ultrasound-based imaging has enabled the detection of
atherosclerosis, and the question is whether CIMT can be a
predictor of PE ina asymptomatic population. The aimof the
study was to evaluate CIMT values in patients who devel-
oped and did not develop PE, and to determine whether
CIMT values could be predictors of PE development.
Patients and methods
The research was prospective cohort study that included 220 pregnant
women who undergone ultrasound examinations at the Materno-
Infantil Presidente Vargas Hospital (HMIPV) in Porto Alegre, Brazil,
from April 2016 to September 2017. Research compared a Gaussian
continuous variable (CIMT) among pregnant women who developed
PE and controls without PE, maintaining a ratio (m) of approximately
13 controls per event according to the expected rate of 7% of pre-
eeclampsia in Brazilian population [14]. A total of 325 pregnantwomen
were screened for the study leading to the expectation of approxi-
mately 25(7.7%) PE and 300 controls, assuming m=13, statistical po-
wer of 90% (β=0.10), type I error of 5% (α=0.05), standard deviation of
0.14 mm and effect size of 0.10 mm.
The examinations were performed every three months. Patients
were divided into two groups. The first group included patients
diagnosedwith PE (n=21) and second group included patientswho did
not have PE (n=199). Each patient signed an informed consent and the
study was approved by the National Ethics Committee, Brazilian
Ministry of Health. All patientsweremonitored during pregnancy. The
criterion for inclusion in the study was pregnant women who monitor
their pregnancy in HMIPV. Exclusion criteriawere as follows:multiple
pregnancy, fetal abnormalities, previously verified hypertension,
diabetes mellitus, thrombophilia, chronic renal disease, previous
pregnancy with PE and molar pregnancy. Demographic and anam-
nestic data on each patient were processed.
The CIMT evaluation was performed in accordance with the
statement From the American Society of Echocardiography CIMT Task
Force as well as in accordance with the 2013 ESH / ESC Guidelines for
the management of arterial hypertension: the Task Force for the
management of arterial hypertension of the European Society of Hy-
pertension (ESH) and European Society of Cardiology (ESC) [15, 16].
Ultrasound was performed while the patients were in a supine posi-
tion. High-resolution B-mode images of the right and left common
carotid arteries were collected using a Samsung HM70A, a device
(Samsung, Seoul, South Korea), equipped with a linear, high- reso-
lution transducer set to 12 MHz. CIMT was defined as mean distance
between intima and media double-line pattern expressed in millime-
ters, measured on both sides of common carotid artery, considering
mean values for analysis, as recommended in previous studies [15–17].
The detection was performed by semi-automated method, since it is
less operator dependent, more reproducible, has lower inter-observer
variation, and provides the average and maximum value of >100
points in a single evaluation compared to the manual method
(Figure 1) [14, 18]. Patients were followed up until the end of their
pregnancy to check whether they developed PE, as defined by the
recommendations of the International Society for the Study of Hy-
pertension in Pregnancy revised in 2014: i.e., onset and maintenance
of hypertension after 20 weeks of gestation in association with sig-
nificant proteinuria [19]. To consider the diagnosis of hypertension,
the systolic BP must have been ≥140 mm Hg and/or diastolic
BP ≥90 mm Hg. For proteinuria to be considered significant, it must
have been ≥300 mg in 24 h urine sample [19]. Quantitative data were
described by mean, standard deviation, minimum, and maximum
values. When distributional assumptions were in doubt, results were
presented in median and interquartile range. Comparisons between
quantitative datawere performedbyStudent’s t-test or rank testswhen
needed. Comparisons between categorical data were performed by χ2-
test or Fisher’s exact test. The relationshipsbetween the variableswere
tested using the parametric Pearson or Spearman correlation. The
results were presented by number of cases, percentage, arithmetic
mean, standard deviation, median with interquartile range, area un-
der the curve (AUC), while receiver operating characteristics (ROC)
curve analysis was used to determine sensitivity and specificity. All
tests were performed with an accuracy level of 95% (p<0.05). Data
were analyzed using IBM-SPSS version 22.0 (IBM Corp., Armonk, NY,
USA) and R version 3.3 (R Foundation for Statistical Computing,
Vienna, Austria).
Results
The mean age of pregnant women was 33.6±14 years for
patients with PE and 30.3±9 years for those without PE.
Patients with PE had, on average, more children than those
without PE (2.38 vs. 1.84). No significant difference in age
or number of pregnancies was found between those with
PE or without PE (p>0.001). The general characteristics of
the study population are given in Table 1. With regard to
the evaluation period of the CMIT, more than half of the
Figure 1: Carotid intima media thickness measured by semi-
automated method.
788 Neto et al.: CIMT as preeclampsia predictor
pregnant women, both in the control group (51.3%) and PE
group (52.4%), underwent CMIT measurement in the first
trimester of pregnancy. No significant correlations were
observed between CIMT and patient’s age (r=0.22; p=0.01),
number of pregnancies (r=0.08; p=0.23), and gestational
period in which the measurement was taken (r=0.02;
p=0.80). Pregnant women with PE had higher CIMT than
normotensive pregnant women (0.55±0.07 vs. 0.45±0.12,
respectively; p<0.001) (Figure 2). After verifying the sig-
nificant difference in CIMT between patients with and
without PE, a ROC curve was constructed to verify if this
test has good accuracy in the diagnosis of PE (Figure 3). The
area under the ROC curves (AUC) was 0.78 and considered
acceptable in the diagnosis of PE. With a CIMT cutoff point
of 0.58 mm, the sensitivity of CIMT to diagnose PE is very
low (28.6%), but the specificity is high (91%). However, if
we choose a CIMT cutoff point of 0.51 mm, the sensitivity
increases to 81%, and the specificity decreases at 77.9%.
When CIMT value was ≥0.6 mm, the probability of the pa-
tient to develop PE was 44.4%; with CIMT <0.5 mm, the
probability was 6.1%, decreasing to 4.2% with CIMT
<0.42 mm (Figure 4).
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Evaluation moment, n (%) .c
First trimester  (.)  (.)
Second trimester  (.)  (.)
Third trimester  (.)  (.)
SD, standard deviation; p, statistical significance; p, median;
p, th percentile; P, th percentile. aStudent’s t-test. bMann–
Whitney U-test. cFisher’s exact test.
Figure 2: Distribution of carotid intima media thickness (CIMT)
values between control (0.46±0.07 mm) and preeclamptic patients
(PE) (0.55±0.12 mm).
Figure 3: Receiver operating characteristics (ROC) curve illustrating
CIMT diagnostic ability for preeclampsia detection.
Figure 4: Bar graph representing the probability of the patient
developing preeclampsia (PE) according to carotid intima media
thickness (CIMT) values.
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Discussion
Increased CIMT is an independent predictor of stroke and
cardiovascular events [20–25]. Eikendal et al. have concluded
in 3,067 adult patients younger than 45 years of age without
symptomatic cardiovascular disease that CIMT may be a
marker for cardiovascular risk [20]. Awad et al. in 89 patients
between 20 and 80 years of age, 88% of patients with hy-
pertension reported an increase in CIMT, 79.2% of those with
diabetes mellitus and 75% of smokers [21]. Baldassarre et al.
showedon sample of 4,482 patients that CIMTwas associated
with increased cardiovascular risk [22], which was also
confirmed by Kokubo et al. in a study on 4,724 patients [24].
Utility of CIMT can predict vascular incident in asymptomatic
patients [25]. InPE, theplacental helixarteries fail to lose their
musculoelastic layers, leading exclusively to decreased
placental perfusion [26]. Milic et al. found that women who
had PE had significantly higher CIMT than those who did not
have PE, at the time of diagnosis and also in the first 10 years
after giving birth [27]. The findings of our study showed that
CIMT in pregnant women with PE was significantly higher
than that in normotensive pregnant women, as has been
similarly demonstrated in studies by other researchers [28–
34]. Memari et al. were comparing 21 pregnant women with
PE and 21 pregnant women without PE. They indicated that
CIMT was significantly higher in carotid arteries [29]. Ster-
giotou et al. stated that early PE was characterized by
increased carotid CIMT diameters, and arterial stiffness with
no significant changes in inferior vena cava parameters as
compared to normotensive pregnancies [30]. Late PE was
characterized by significantly increased CIMT and lumen di-
ameters as compared to controls while arterial stiffness, as
expressed by distensibility, did not provide pronounced
changes [30]. A significant decrease in inferior vena cava
collapse index was also observed in late PE as compared to
control [30]. Yuan et al. have concluded that changes in
arterial internal diameter of carotids, wall thickness and
arterial stiffening occur in PE, but this may reverse after giv-
ing birth [31]. Mori et al. have shown that pre-existing hy-
pertension is a factor leading to an increase in CIMT, and
concluded that endothelial dysfunction induced by
enhanced oxidative stress is reversible in women with PE,
and that vascular reactivity itself may be associated with
earlier changes in hypertension [32]. In our study, sensitivity
of PE predicting was 81% with a cutoff point of CIMT of
0.51 mm, while if CIMT ≥0.6 mm, the probability of pacient
develop preeclampsia is 44.4%. Magnussen et al. stated that
estimated cardiovascular risk before pregnancy was associ-
atedwith the onset of PE, and stated that already existing risk
factors for cardiovascular diseasemay lead to the onset of PE
and cardiovascular disease [33]. This lead to the conclusion
that optimal treatment of cardiovascular pathology was also
of particular importance inwomenwho plan their pregnancy
[34]. Milic et al. concluded that atherosclerotic load is present
in preeclamptic pregnancies and that it may be one of the
mechanisms leading to this disease [34]. Radiologist should
do CIMT measurements from the 20th week of pregnancy,
because that is the moment when PE could appear. CIMT
measurements should be considered as supportivemethod in
addition to biochemical and ultrasound parameters, which
could assist the gynecologist in screening and preventing PE.
Our research limits the number of patients with PE enrolled,
but nonetheless, the research offers useful information that
CIMT could be a predictor of PE in a previously asymptomatic
population, and indicates that atherosclerosis is also one of
the etiologic factors for PE. Continued follow-up of these
patients after delivery may be the basis for a new study in
which theoccurrenceofPEcouldbeassociatedwith theonset
of a cardiovascular incident.
Conclusions
An increase in CIMT was associated with the onset of PE.
CIMT values were significantly higher in patients who
develop PE. Early identification of high-risk patients in
prevention of PE is imperative in the work of gynecologists
and CIMT may be additional marker, which will be with
other biochemical and ultrasound parameters a part of the
mosaic that could predict the occurrence of PE.
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